Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein

doi:10.1084/jem.176.2.623

This Article

	Full Text (PDF, 520K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Sy, M. S.
	Articles by Stamenkovic, I.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Sy, M. S.
	Articles by Stamenkovic, I.


Social Bookmarking

	What's this?

ARTICLES

Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein

MS Sy, YJ Guo and I Stamenkovic
Department of Pathology, Massachusetts General Hospital, Charlestown.

CD44H is the principal cell surface receptor for hyaluronate, which is a major glycosaminoglycan of the extracellular matrix. Expression of CD44H is enhanced in a variety of malignant tumors and correlates with tumor aggressiveness, supporting the notion that interaction between CD44H and hyaluronate may play an important role in tumor growth and dissemination. In this report we show that in vivo tumor formation by human lymphoma Namalwa cells, stably transfected with CD44H, can be suppressed by a soluble human CD44H-immunoglobulin fusion protein. Disruption of the interaction between CD44H and its physiologic ligands may provide a novel strategy for controlling tumor growth in vivo.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Becerra, S. P., Perez-Mediavilla, L. A., Weldon, J. E., Locatelli-Hoops, S., Senanayake, P., Notari, L., Notario, V., Hollyfield, J. G. (2008). Pigment Epithelium-derived Factor Binds to Hyaluronan: MAPPING OF A HYALURONAN BINDING SITE. J. Biol. Chem. 283: 33310-33320 [Abstract] [Full Text]
Ouhtit, A., Abd Elmageed, Z. Y., Abdraboh, M. E., Lioe, T. F., Raj, M. H.G. (2007). In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver. Am. J. Pathol. 171: 2033-2039 [Abstract] [Full Text]
Knepper, P. A., Miller, A. M., Choi, J., Wertz, R. D., Nolan, M. J., Goossens, W., Whitmer, S., Yue, B. Y. J. T., Ritch, R., Liebmann, J. M., Allingham, R. R., Samples, J. R. (2005). Hypophosphorylation of Aqueous Humor sCD44 and Primary Open-Angle Glaucoma. IOVS 46: 2829-2837 [Abstract] [Full Text]
Avin, E., Haimovich, J., Hollander, N. (2004). Anti-Idiotype x Anti-CD44 Bispecific Antibodies Inhibit Invasion of Lymphoid Organs by B Cell Lymphoma. J. Immunol. 173: 4736-4743 [Abstract] [Full Text]
Xu, X.-M., Chen, Y., Chen, J., Yang, S., Gao, F., Underhill, C. B., Creswell, K., Zhang, L. (2003). A Peptide with Three Hyaluronan Binding Motifs Inhibits Tumor Growth and Induces Apoptosis. Cancer Res. 63: 5685-5690 [Abstract] [Full Text]
Toole, B. P. (2002). Hyaluronan promotes the malignant phenotype. Glycobiology 12: 37R-42R [Abstract] [Full Text]
Eliaz, R. E., Szoka, F. C. Jr. (2001). Liposome-encapsulated Doxorubicin Targeted to CD44: A Strategy to Kill CD44-overexpressing Tumor Cells. Cancer Res. 61: 2592-2601 [Abstract] [Full Text]
Liu, N., Lapcevich, R. K., Underhill, C. B., Han, Z., Gao, F., Swartz, G., Plum, S. M., Zhang, L., Green, S. J. (2001). Metastatin: A Hyaluronan-binding Complex from Cartilage That Inhibits Tumor Growth. Cancer Res. 61: 1022-1028 [Abstract] [Full Text]
Biancone, L., Stamenkovic, I., Cantaluppi, V., Boccellino, M., De Martino, A., Bussolino, F., Camussi, G. (1999). Expression of L-Selectin Ligands by Transformed Endothelial Cells Enhances T Cell-Mediated Rejection. J. Immunol. 162: 5263-5269 [Abstract] [Full Text]
Lessan, K., Aguiar, D. J., Oegema, T., Siebenson, L., Skubitz, A. P. N. (1999). CD44 and �1 Integrin Mediate Ovarian Carcinoma Cell Adhesion to Peritoneal Mesothelial Cells. Am. J. Pathol. 154: 1525-1537 [Abstract] [Full Text]
Banerji, S., Ni, J., Wang, S.-X., Clasper, S., Su, J., Tammi, R., Jones, M., Jackson, D. G. (1999). LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan. JCB 144: 789-801 [Abstract] [Full Text]
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., Pals, S. T. (1999). Expression of CD44 in Apc and Tcf Mutant Mice Implies Regulation by the WNT Pathway. Am. J. Pathol. 154: 515-523 [Abstract] [Full Text]
Martegani, M. P., Del Prete, F., Gasbarri, A., Natali, P. G., Bartolazzi, A. (1999). Structural Variability of CD44v Molecules and Reliability of Immunodetection of CD44 Isoforms Using mAbs Specific for CD44 Variant Exon Products. Am. J. Pathol. 154: 291-300 [Abstract] [Full Text]
Yu, Q., Toole, B. P., Stamenkovic, I. (1997). Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function. JEM 186: 1985-1996 [Abstract] [Full Text]
Bartolazzi, A, Jackson, D, Bennett, K, Aruffo, A, Dickinson, R, Shields, J, Whittle, N, Stamenkovic, I (1995). Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J. Cell Sci. 108: 1723-1733 [Abstract]
Bertolami, C. N., Messadi, D. V. (1994). The Role of Proteoglycans in Hard and Soft Tissue Repair. CROBM 5: 311-337 [Abstract] [Full Text]
Vincent, T., Jourdan, M., Sy, M.-S., Klein, B., Mechti, N. (2001). Hyaluronic Acid Induces Survival and Proliferation of Human Myeloma Cells through an Interleukin-6-mediated Pathway Involving the Phosphorylation of Retinoblastoma Protein. J. Biol. Chem. 276: 14728-14736 [Abstract] [Full Text]